Crossmark Global Holdings’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $261K | Hold |
5,523
| – | – | ﹤0.01% | 1127 |
|
|
2026
Q1 | $327K | Sell |
5,523
-34
| -0.6% | -$2.21K | ﹤0.01% | 985 |
|
|
2025
Q4 | $343K | Buy |
5,557
+1,825
| +49% | +$112K | ﹤0.01% | 978 |
|
|
2025
Q3 | $233K | Sell |
3,732
-109
| -3% | -$7.59K | ﹤0.01% | 1198 |
|
|
2025
Q2 | $307K | Sell |
3,841
-4
| -0.1% | -$335 | 0.01% | 1086 |
|
|
2025
Q1 | $331K | Buy |
3,845
+29
| +0.8% | +$2.38K | 0.01% | 1042 |
|
|
2024
Q4 | $298K | Sell |
3,816
-82
| -2% | -$6.37K | 0.01% | 1047 |
|
|
2024
Q3 | $281K | Sell |
3,898
-56
| -1% | -$3.97K | 0.01% | 1111 |
|
|
2024
Q2 | $272K | Sell |
3,954
-289
| -7% | -$19.6K | 0.01% | 1106 |
|
|
2024
Q1 | $308K | Hold |
4,243
| – | – | 0.01% | 1081 |
|
|
2023
Q4 | $260K | Sell |
4,243
-1,570
| -27% | -$93.2K | 0.01% | 1139 |
|
|
2023
Q3 | $343K | Sell |
5,813
-165
| -3% | -$9.97K | 0.01% | 951 |
|
|
2023
Q2 | $389K | Buy |
5,978
+22
| +0.4% | +$1.32K | 0.01% | 953 |
|
|
2023
Q1 | $373K | Sell |
5,956
-132
| -2% | -$8.24K | 0.01% | 947 |
|
|
2022
Q4 | $381K | Buy |
6,088
+308
| +5% | +$17.7K | 0.01% | 914 |
|
|
2022
Q3 | $288K | Sell |
5,780
-30
| -0.5% | -$1.66K | 0.01% | 1010 |
|
|
2022
Q2 | $341K | Sell |
5,810
-350
| -6% | -$19.3K | 0.01% | 974 |
|
|
2022
Q1 | $327K | Buy |
6,160
+90
| +1% | +$5.2K | 0.01% | 1099 |
|
|
2021
Q4 | $368K | Buy |
6,070
+400
| +7% | +$23.7K | 0.01% | 1048 |
|
|
2021
Q3 | $318K | Sell |
5,670
-490
| -8% | -$26.9K | 0.01% | 1140 |
|
|
2021
Q2 | $321K | Buy |
6,160
+130
| +2% | +$6.24K | 0.01% | 1142 |
|
|
2021
Q1 | $266K | Buy |
+6,030
| New | +$253K | 0.01% | 1236 |
|
|
2020
Q3 | – | Sell |
-5,450
| Closed | -$205K | – | 1359 |
|
|
2020
Q2 | $205K | Sell |
5,450
-440
| -7% | -$17.6K | 0.01% | 1224 |
|
|
2020
Q1 | $216K | Sell |
5,890
-50
| -0.8% | -$1.94K | 0.01% | 1016 |
|
|
2019
Q4 | $241K | Buy |
+5,940
| New | +$222K | 0.01% | 1246 |
|
|
2018
Q4 | – | Sell |
-6,366
| Closed | -$241K | – | 1513 |
|
|
2018
Q3 | $241K | Sell |
6,366
-70
| -1% | -$2.65K | 0.01% | 1450 |
|
|
2018
Q2 | $247K | Buy |
6,436
+190
| +3% | +$6.41K | 0.01% | 1431 |
|
|
2018
Q1 | $211K | Sell |
6,246
-686
| -10% | -$26.3K | 0.01% | 1474 |
|
|
2017
Q4 | $308K | Buy |
6,932
+476
| +7% | +$21.7K | 0.01% | 1351 |
|
|
2017
Q3 | $323K | Buy |
+6,456
| New | +$330K | 0.01% | 1268 |
|
|
2016
Q3 | $323K | Buy |
+6,456
| New | +$327K | 0.01% | 1268 |
|
Other funds holding PBH
AI
BIP
Crossmark Global Holdings's PBH Position: Q2 2026 in Review
Crossmark Global Holdings held its Prestige Consumer Healthcare (PBH) position steady in Q2 2026 at 5,523 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1127.
Crossmark Global Holdings first reported a position in PBH in Q3 2016 and has held it in 31 quarters since. The position peaked at $389K in Q2 2023. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.
- Crossmark Global Holdings held 5,523 shares of Prestige Consumer Healthcare worth $261K as of Q2 2026.
- Crossmark Global Holdings left its Prestige Consumer Healthcare share count unchanged in Q2 2026.
- Prestige Consumer Healthcare made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1127 holding.
- Crossmark Global Holdings first reported a position in Prestige Consumer Healthcare in Q3 2016 and has held it in 31 quarters since.
- Crossmark Global Holdings's Prestige Consumer Healthcare position peaked at $389K in Q2 2023.
- 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.